Profil
John Hunter formerly worked at XOMA Royalty Corp., as Senior Director, Compugen Ltd., as Chief Scientific Officer, Compugen, Inc. (United States), as Vice President-Antibody R&D, Keyhole Therapeutics, Inc., as Chief Executive & Scientific Officer, and FibroGen, Inc., as Chief Scientific Officer from 2021 to 2024.
Dr. Hunter received his undergraduate degree from Hartwick College and doctorate degree from The University of California, San Francisco.
Anciens postes connus de John Hunter
| Sociétés | Poste | Fin |
|---|---|---|
| KYNTRA BIO, INC. | Directeur Technique/Scientifique/R&D | 01/10/2024 |
| XOMA ROYALTY CORPORATION | Directeur/Membre du Conseil | - |
Keyhole Therapeutics, Inc.
Keyhole Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a discovery stage drug company that specializes immunotherapies for cancer and autoimmune diseases | Directeur Général | - |
| COMPUGEN LTD. | Directeur Technique/Scientifique/R&D | - |
Compugen, Inc. (United States) | Corporate Officer/Principal | - |
Formation de John Hunter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Compugen Ltd.
Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
FibroGen, Inc.
FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Hartwick College
Hartwick College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compugen, Inc. (United States) | |
Keyhole Therapeutics, Inc.
Keyhole Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a discovery stage drug company that specializes immunotherapies for cancer and autoimmune diseases | Health Technology |
















